Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jtct.2023.06.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "Effectiveness of nurse-delivered stepwise swallowing training on dysphagia in patients with Alzheimer's disease: A multi-center randomized controlled trial" [Int. J. Nurs. Stud. 150 (2024) 104649].
Int J Nurs Stud
December 2024
Geriatric Neuroscience Center, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China; Department of Nursing, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. Electronic address:
Corrigendum to Endoscopic powered resection device for residual colonic lesions: the first multicenter, prospective, international clinical study. Gastrointestinal Endoscopy Volume 99, Issue 5, May 2024, Pages 778-786.
Gastrointest Endosc
December 2024
Digestive Endoscopy Unit, Università Cattolica del Sacro Cuore, Rome, Italy, Digestive Endoscopy Unit, Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome, Italia.
Corrigendum to 'Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States' [Clinical Lymphoma, Myeloma, and Leukemia Volume 24, Issue 8, August 2024, Pages 523-530].
Clin Lymphoma Myeloma Leuk
December 2024
City of Hope Medical Center, Duarte, CA.
Corrigendum to "Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774)" [Eur Urol. 86(1) (2024) 52-60].
Eur Urol
January 2025
Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA. Electronic address:
Corrigendum to "Prognostic and predictive value of CA 19-9 inlocally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)": [ESMO Open 7 (2024) 100552].
ESMO Open
October 2024
Department of Internal Medicine II, Medical Oncology and Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!